FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/031965 [Registered on: 15/03/2021] Trial Registered Prospectively
Last Modified On: 26/08/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Brain Exercises for better memory 
Scientific Title of Study   Brain Exercises for better cognitive functioning 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dheeraj Khurana 
Designation  Professor 
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Neurology, PGIMER, Chandigarh
Department of Neurology, PGIMER, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  7087009695  
Fax    
Email  khurana.dheeraj@pgimer.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dheeraj Khurana 
Designation  Professor 
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Neurology, PGIMER, Chandigarh
Department of Neurology, PGIMER, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  7087009695  
Fax    
Email  khurana.dheeraj@pgimer.edu.in  
 
Details of Contact Person
Public Query
 
Name  Mandeep 
Designation  Women Scientist  
Affiliation  Post Graduate Institute of Medical Education and Research 
Address  Department of Neurology, PGIMER, Chandigarh
Department of Neurology, PGIMER, Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  9888124449  
Fax    
Email  axon.mandeep@gmail.com  
 
Source of Monetary or Material Support  
Department of Science and Technology, Women Scientist Scheme (WOS B) KIRAN Division, Department of Science and Technology (DST), Technology Bhawan, New Mehrauli Road, New Delhi- 110016.  
 
Primary Sponsor  
Name  Department of Science and Technology 
Address  KIRAN Division, Department of Science and Technology (DST), Technology Bhawan, New Mehrauli Road, New Delhi- 110016. 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priti Arun  Government Medical College and Hospital  Department of Psychiatry, Government Medical College and Hospital, Sector 32, Chandigarh
Chandigarh
CHANDIGARH 
9646121612

drpritiarun@gmail.com 
Dr Dheeraj Khurana  Post Graduate Institute of Medical Education and Research  Department of Neurology PGIMER, Chandigarh
Chandigarh
CHANDIGARH 
7087009695

khurana.dheeraj@pgimer.edu.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institute Ethical Committee  Approved 
Institutional Ethics Core Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G00-G99||Diseases of the nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cognitive Intervention and Physical Intervention Duration and Frequency: 45 minutes 6 days a week   Cognitive Rehabilitation Intervention- Restorative and compensatory cognitive rehabilitation Physical Rehabilitation Intervention- Walking, Balance exercises, Strengthening Exercises, Range of Motion Exercises,  
Comparator Agent  Standard of Care  Medication and general instructions by treating physician 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Literacy level - High school completed (minimum qualification 10th Standard)
2. A baseline MoCA (Montreal Cognitive Assessment) score- 18 -25
3. DSM 5 diagnostic criteria for mild neuro cognitive disorder
4. Be screened safe for exercise by a physician
5. Normal auditory/visual acuity (with/without spectacles; no hearing aid)
6. Able to comply with rehabilitation program and can come for follow up
7. Willing to participate in the study and signed Informed consent.
8. Patients who have provided written consent and are willing to participate in the study. 
 
ExclusionCriteria 
Details  1. Severe Dementia (Clinical Dementia Rating Score>1) Alzheimer’s Disease or other progressive neurodegenerative /neuropsychiatric diseases.
2. Depression (Geriatric Depression Scale score 0-9)
3. Reversible dementia (Vit B12 deficiency, Thyroid dysfunction)
4. Any clinical dementia with co-existing neuropsychiatric disorder/head injury or terminal illness/ progressive neurodegenerative disorder.
5. Unstable cardiovascular disease that precludes exercise
6. Musculoskeletal impairments/pain or co-morbidities that limit ability to exercise/walk/use of walking aid. Berg balance scale score <40
7. Patient taking drugs that affect cognition (opioids, anti-psychotics/anticholinergics, tricyclic, anti-depressants, mood stabilizers, benzodiazepines and non- benzodiazepine, hypnotics, muscle relaxants, antihistamines, anti-epileptics)
8. History of prolonged alcohol or substance abuse
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
IQ CODE
SF-36 (rand)
IADL-EDR 
Baseline,4 weeks and 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
ICMR-NTB
Memory, Attention and Executive Function Domains

Category Fluency, Verbal Memory, TMT, Picture Naming, Immediate Recall, Interference Test, Free recall, Cued recall, Spatial Recall
 
1-Month
3- Month 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Mild Cognitive Impairment and Dementia are common health problems faced by adults and the elderly. Objective evidence of cognitive impairment is evident in both conditions. Directing cognitive and physical rehabilitation may improve the cognitive impairment. Evidences suggests physical and cognitive activities benefit the cognition. 

The main objective of this study is to find the effectiveness of combined physical and cognitive rehabilitation in improving the cognitive impairment.

Study Design-  Randomised control trial

Research Setting- Departmnet of Neurology, PGIMER, Chandigarh

Study Population- Mild Cognitive Impairment and Mild Dementia

Sample Size- 60 patients-  30 patients in each arm.

Recruitment Criteria- Inclusion criteria- 1) 45-70 years age 2)  literacy level- at least 10th standard 3) MoCA score- 14-25 4) Normal auditory/ visual acuity )with/wothout spectacles and hearing aid) 5) Able to comply with rehabilitation program 6) willing to participate in thestudy and signed informed consent
Exclusion Criteria- 1) Severe Dementia (Clinical Dementia rating scale>1) Alheimer’s disease or other progressive neurodegenerative / neuropsychiatric disease 2) Depression,  Reversible dementia andclinical dementia with co-existing neuropsychiatric disorder/ head injury or terminal illnesses. 3) Unstable cardiovascular disease that preclude ofysical exercises 4) Musculoskeletal impairments or co-morbidities that limit ability to do exercises Berg balancescale <40 5) Ptient taking drugs that affect cognition  6) History of prolonged alcohol or substance abuse.

Patient recruitment- Study participants will be randomly assigned by simple ransomization into intervention group and control group.
Intervention group will receive combined cognitive and physical rehabilitation. Control group will receive standard of care.

Primary Outcome- IQ CODE, SF 36 (RAND) , IADL-EDR
Secondary Outcome- Attention, Memory and Executive domains of ICMR-NTB. 



 
Close